CR Group L.P. - 19 Sep 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
10%+ Owner
Signature
/s/ Nathan D. Hukill, authorized signatory for CRG Partners III L.P., CRG Partners III Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P., and CRG Partners III (Cayman) Lev AIV I L.P.
Issuer symbol
TTOO
Transactions as of
19 Sep 2023
Net transactions value
-$3,806,937
Form type
4
Filing time
21 Sep 2023, 16:30:32 UTC
Previous filing
09 Aug 2023
Next filing
22 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Sale $1,522,456 -4,159,717 -22% $0.3660 15,174,560 19 Sep 2023 By CRG Partners III L.P. F1, F2
transaction TTOO Common Stock Sale $948,050 -2,590,300 -22% $0.3660 9,449,360 19 Sep 2023 By CRG Partners III ? Parallel Fund ?A? L.P. F1, F2
transaction TTOO Common Stock Sale $304,491 -831,943 -22% $0.3660 3,034,912 19 Sep 2023 By CRG Partners III (Cayman) Unlev AIV I L.P. F1, F2
transaction TTOO Common Stock Sale $1,031,939 -2,819,506 -22% $0.3660 10,285,500 19 Sep 2023 By CRG Partners III (Cayman) Lev AIV I L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.33 to $0.4136, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
F2 CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.